| No. of | No. of |  | Hazard ratio (95% confidence interval) | ||
---|---|---|---|---|---|---|
Quartiles of LFD score | Participants | Cases | Person-years | Unadjusted | Model 1a | Model 2b |
HNC | 98,459 | 268 | Â | Â | Â | Â |
Quartile 1 (≤ 10) | 26,715 | 101 | 232483.5 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
Quartile 2 (11–15) | 26,151 | 69 | 229877.9 | 0.69 (0.51, 0.94) | 0.71 (0.52, 0.96) | 0.75 (0.56, 1.03) |
Quartile 3 (16–20) | 24,764 | 65 | 220840.0 | 0.68 (0.50, 0.92) | 0.75 (0.55, 1.03) | 0.85 (0.62, 1.16) |
Quartile 4 (≥ 21) | 20,829 | 33 | 188678.3 | 0.40 (0.27, 0.59) | 0.51 (0.34, 0.75) | 0.60 (0.40, 0.90) |
P for trend |  |  |  | < 0.001 | 0.001 | 0.026 |
Oral Cavity and Pharynx cancer | 98,352 | 161 | Â | Â | Â | Â |
Quartile 1 (≤ 10) | 26,669 | 55 | 232261.3 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
Quartile 2 (11–15) | 26,127 | 45 | 229760.9 | 0.83 (0.56, 1.22) | 0.84 (0.57, 1.24) | 0.88 (0.59, 1.31) |
Quartile 3 (16–20) | 24,736 | 37 | 220692.6 | 0.71 (0.47, 1.07) | 0.75 (0.49, 1.14) | 0.82 (0.54, 1.25) |
Quartile 4 (≥ 21) | 20,820 | 24 | 188639.7 | 0.53 (0.33, 0.86) | 0.62 (0.38, 1.00) | 0.70 (0.43, 1.15) |
P for trend | Â | Â | Â | 0.007 | 0.039 | 0.147 |
Larynx cancer | 98,287 | 96 | Â | Â | Â | Â |
Quartile 1 (≤ 10) | 26,660 | 46 | 232228.3 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
Quartile 2 (11–15) | 26,100 | 18 | 229634.0 | 0.40 (0.23, 0.68) | 0.41 (0.24, 0.71) | 0.45 (0.26, 0.78) |
Quartile 3 (16–20) | 24,722 | 23 | 220613.7 | 0.53 (0.32, 0.87) | 0.62 (0.38, 1.03) | 0.75 (0.45, 1.24) |
Quartile 4 (≥ 21) | 20,805 | 9 | 188546.9 | 0.24 (0.12, 0.49) | 0.35 (0.17, 0.73) | 0.46 (0.22, 0.96) |
P for trend |  |  |  | < 0.001 | 0.003 | 0.039 |